Age-related macular degeneration: prevention and treatment. A review

Age-related macular degeneration (AMD) is a multifactorial disease. Age, light exposure, smoking, melanin levels and low-antioxidant diet are contributed to AMD development and progression. Cardiovascular disorders are of considerable importance as well. In macula, photoreceptor outer segments that...

Full description

Bibliographic Details
Main Author: K. A. Mirzabekova
Format: Article
Language:Russian
Published: Ophthalmology Publishing Group 2014-07-01
Series:Oftalʹmologiâ
Subjects:
amd
Online Access:https://www.ophthalmojournal.com/opht/article/view/18
id doaj-4d9b3d4c1c5746739f44bb0214f5fdf8
record_format Article
spelling doaj-4d9b3d4c1c5746739f44bb0214f5fdf82021-07-29T08:55:20ZrusOphthalmology Publishing GroupOftalʹmologiâ 1816-50952014-07-011124910.18008/1816-5095-2014-2-4-918Age-related macular degeneration: prevention and treatment. A reviewK. A. Mirzabekova0Research Institute of Eye Diseases of Russian Academy of SciencesAge-related macular degeneration (AMD) is a multifactorial disease. Age, light exposure, smoking, melanin levels and low-antioxidant diet are contributed to AMD development and progression. Cardiovascular disorders are of considerable importance as well. In macula, photoreceptor outer segments that are rich in polyunsaturated fatty acids (FA), particularly, docosahexaenoic acid (DHA), are susceptible to free radicals damage. High blood flow velocity and oxygen partial pressure as well as direct sunlight exposure induce oxidative processes. The source of free radicals in photoreceptor cells and retinal pigment epithelium (RPE) is an extensive mitochondrial metabolism, photoreceptor outer segments phagocytosis, lipofuscin phototoxic activity and hemoglobin or protoporphyrin precursors photosensitization. Oxidative stress is considered as an universal component of cell depth in necrosis, apoptosis and toxic damage. Antioxidant protective system consists of enzymes (superoxide dismutase, glutathione peroxidase and catalase) and non-enzymatic factors (ascorbic acid, alpha tocopherol, retinol, carotenoids). Specific antioxidant food supplement containing ascorbic acid (500 mg), vitamin E (400 IU) and beta carotene (15 mg) coupled with zinc (80 mg of zinc oxide) and copper (2 mg of copper oxide) results in 25 % decrease in late-stage AMD development rate. Amongst the agents that can protect retina from oxidative stress and AMD development, carotenoids are of special importance. Lutein and zeaxanthin containing in retina and lens screen blue light from central area of the retina. They also absorb blue light and inhibit free radicals generation thus preventing polyunsaturated FA light destruction. Association between lutein and zeaxanthin intake and late-stage AMD risk was revealed. Amongst the most important factors which deficiency favors macular degeneration are omega-3 FAs, i.e., DHA. DHA is the key component of visual pigment rhodopsin transformation. It requires for nerve impulse generation.https://www.ophthalmojournal.com/opht/article/view/18amdantioxidantsluteinzeaxanthin.
collection DOAJ
language Russian
format Article
sources DOAJ
author K. A. Mirzabekova
spellingShingle K. A. Mirzabekova
Age-related macular degeneration: prevention and treatment. A review
Oftalʹmologiâ
amd
antioxidants
lutein
zeaxanthin.
author_facet K. A. Mirzabekova
author_sort K. A. Mirzabekova
title Age-related macular degeneration: prevention and treatment. A review
title_short Age-related macular degeneration: prevention and treatment. A review
title_full Age-related macular degeneration: prevention and treatment. A review
title_fullStr Age-related macular degeneration: prevention and treatment. A review
title_full_unstemmed Age-related macular degeneration: prevention and treatment. A review
title_sort age-related macular degeneration: prevention and treatment. a review
publisher Ophthalmology Publishing Group
series Oftalʹmologiâ
issn 1816-5095
publishDate 2014-07-01
description Age-related macular degeneration (AMD) is a multifactorial disease. Age, light exposure, smoking, melanin levels and low-antioxidant diet are contributed to AMD development and progression. Cardiovascular disorders are of considerable importance as well. In macula, photoreceptor outer segments that are rich in polyunsaturated fatty acids (FA), particularly, docosahexaenoic acid (DHA), are susceptible to free radicals damage. High blood flow velocity and oxygen partial pressure as well as direct sunlight exposure induce oxidative processes. The source of free radicals in photoreceptor cells and retinal pigment epithelium (RPE) is an extensive mitochondrial metabolism, photoreceptor outer segments phagocytosis, lipofuscin phototoxic activity and hemoglobin or protoporphyrin precursors photosensitization. Oxidative stress is considered as an universal component of cell depth in necrosis, apoptosis and toxic damage. Antioxidant protective system consists of enzymes (superoxide dismutase, glutathione peroxidase and catalase) and non-enzymatic factors (ascorbic acid, alpha tocopherol, retinol, carotenoids). Specific antioxidant food supplement containing ascorbic acid (500 mg), vitamin E (400 IU) and beta carotene (15 mg) coupled with zinc (80 mg of zinc oxide) and copper (2 mg of copper oxide) results in 25 % decrease in late-stage AMD development rate. Amongst the agents that can protect retina from oxidative stress and AMD development, carotenoids are of special importance. Lutein and zeaxanthin containing in retina and lens screen blue light from central area of the retina. They also absorb blue light and inhibit free radicals generation thus preventing polyunsaturated FA light destruction. Association between lutein and zeaxanthin intake and late-stage AMD risk was revealed. Amongst the most important factors which deficiency favors macular degeneration are omega-3 FAs, i.e., DHA. DHA is the key component of visual pigment rhodopsin transformation. It requires for nerve impulse generation.
topic amd
antioxidants
lutein
zeaxanthin.
url https://www.ophthalmojournal.com/opht/article/view/18
work_keys_str_mv AT kamirzabekova agerelatedmaculardegenerationpreventionandtreatmentareview
_version_ 1721251155890143232